Successful rapid oral clindamycin desensitization in a pediatric patient

J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2141-2142. doi: 10.1016/j.jaip.2018.04.004. Epub 2018 Apr 12.

Authors

Brittany Esty¹, Samantha Minnicozzi¹, Esther Chang Chu², Ana Dioun Broyles¹, Christina S K Yee³

Affiliations

¹ Division of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
² Department of Pharmacy, Boston Children's Hospital, Boston, Mass.
³ Division of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address: Christina.Yee@childrens.harvard.edu.

PMID: 29655773
DOI: 10.1016/j.jaip.2018.04.004

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Allergens / immunology*
Anaphylaxis / diagnosis
Anaphylaxis / immunology
Anaphylaxis / therapy*
Anti-Bacterial Agents / immunology*
Anti-Bacterial Agents / therapeutic use
Cefazolin / immunology
Cefazolin / therapeutic use
Child
Clindamycin / immunology*
Clindamycin / therapeutic use
Desensitization, Immunologic / methods*
Drug Hypersensitivity / diagnosis
Drug Hypersensitivity / immunology
Drug Hypersensitivity / therapy*
Edema
Exanthema
Female
Humans
Pruritus
Skin Tests
Withholding Treatment

Substances

Allergens
Anti-Bacterial Agents
Clindamycin
Cefazolin